X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (48) 48
female (41) 41
index medicus (40) 40
adult (34) 34
male (28) 28
middle aged (28) 28
risk factors (28) 28
oncology (23) 23
aged (21) 21
cancer (21) 21
case-control studies (20) 20
cervical cancer (18) 18
papillomavirus infections (18) 18
research (18) 18
adolescent (16) 16
epidemiology (15) 15
health aspects (15) 15
head and neck cancer (14) 14
head and neck neoplasms - epidemiology (14) 14
public, environmental & occupational health (14) 14
prevalence (13) 13
young adult (13) 13
article (12) 12
human papillomavirus (12) 12
papillomavirus infections - epidemiology (12) 12
smoking (12) 12
alcohol (11) 11
odds ratio (11) 11
oral-cancer (11) 11
papillomaviruses (11) 11
vaccines (11) 11
age factors (10) 10
analysis (10) 10
papillomavirus infections - prevention & control (10) 10
prevention (10) 10
upper aerodigestive tract (10) 10
aged, 80 and over (9) 9
genotype (9) 9
papillomaviridae - genetics (9) 9
risk (9) 9
squamous-cell carcinoma (9) 9
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (8) 8
hpv (8) 8
infection (8) 8
life sciences (8) 8
oncology, experimental (8) 8
papillomavirus infections - virology (8) 8
pharyngeal cancer (8) 8
santé publique et épidémiologie (8) 8
tobacco (8) 8
uterine cervical neoplasms - prevention & control (8) 8
clinical trials (7) 7
infectious diseases (7) 7
logistic models (7) 7
research article (7) 7
alcohol drinking (6) 6
alcohol drinking - adverse effects (6) 6
alcohol drinking - epidemiology (6) 6
follow-up studies (6) 6
head (6) 6
hematology, oncology and palliative medicine (6) 6
human-papillomavirus infection (6) 6
international head (6) 6
papillomavirus infections - complications (6) 6
papillomavirus vaccines - administration & dosage (6) 6
papil·lomavirus (6) 6
pooled analysis (6) 6
public health (6) 6
smoking - epidemiology (6) 6
women (6) 6
womens health (6) 6
young-women (6) 6
age (5) 5
care and treatment (5) 5
cervical intraepithelial neoplasia - prevention & control (5) 5
cervical intraepithelial neoplasia - virology (5) 5
cervix (5) 5
dna (5) 5
dna, viral - analysis (5) 5
double-blind method (5) 5
female genital diseases and pregnancy complications (5) 5
genetic aspects (5) 5
head & neck cancer (5) 5
head and neck neoplasms (5) 5
head and neck neoplasms - etiology (5) 5
head and neck neoplasms - genetics (5) 5
human papillomavirus 16 - immunology (5) 5
incidence (5) 5
medical and health sciences (5) 5
medical research (5) 5
medicin och hälsovetenskap (5) 5
men (5) 5
papillomavirus infections - diagnosis (5) 5
particle vaccine (5) 5
smoking - adverse effects (5) 5
time factors (5) 5
united-states (5) 5
uterine cervical neoplasms - epidemiology (5) 5
uterine cervical neoplasms - virology (5) 5
virus diseases (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by de Sanjose, Silvia, Dr and Quint, Wim GV, PhD and Alemany, Laia, MD and Geraets, Daan T, MSc and Klaustermeier, Jo Ellen, BSc and Lloveras, Belen, MD and Tous, Sara, BSc and Felix, Ana, MD and Bravo, Luis Eduardo, MD and Shin, Hai-Rim, MD and Vallejos, Carlos S, MD and de Ruiz, Patricia Alonso, Prof and Lima, Marcus Aurelho, MD and Guimera, Nuria, BSc and Clavero, Omar, MD and Alejo, Maria, MD and Llombart-Bosch, Antonio, Prof and Cheng-Yang, Chou, MD and Tatti, Silvio Alejandro, Prof and Kasamatsu, Elena, Prof and Iljazovic, Ermina, MD and Odida, Michael, MD and Prado, Rodrigo, Prof and Seoud, Muhieddine, Prof and Grce, Magdalena, PhD and Usubutun, Alp, Prof and Jain, Asha, MD and Suarez, Gustavo Adolfo Hernandez, MD and Lombardi, Luis Estuardo, MD and Banjo, Aekunbiola, MD and Menéndez, Clara, MD and Domingo, Efrén Javier, MD and Velasco, Julio, MD and Nessa, Ashrafun, MD and Chichareon, Saibua C Bunnag, MD and Qiao, You Lin, Prof and Lerma, Enrique, Prof and Garland, Suzanne M, MD and Sasagawa, Toshiyuki, MD and Ferrera, Annabelle, Prof and Hammouda, Doudja, MD and Mariani, Luciano, MD and Pelayo, Adela, Prof and Steiner, Ivo, Prof and Oliva, Esther, MD and Meijer, Chris JLM, Prof and Al-Jassar, Waleed Fahad, MD and Cruz, Eugenia, MD and Wright, Thomas C, MD and Puras, Ana, MD and Llave, Cecilia Ladines, MD and Tzardi, Maria, MD and Agorastos, Theodoros, Prof and Garcia-Barriola, Victoria, MD and Clavel, Christine, PhD and Ordi, Jaume, Prof and Andújar, Miguel, MD and Castellsagué, Xavier, MD and Sánchez, Gloria I, PhD and Nowakowski, Andrzej Marcin, MD and Bornstein, Jacob, Prof and Muñoz, Nubia, MD and Bosch, F Xavier, MD and HPV Time Trends Study Grp and Retrospective Int Survey and Retrospective International Survey and HPV Time Trends Study Group
Lancet Oncology, ISSN 1470-2045, 2010, Volume 11, Issue 11, pp. 1048 - 1056
Summary Background Knowledge about the distribution of human papillomavirus (HPV) genotypes in invasive cervical cancer is crucial to guide the introduction of... 
Hematology, Oncology and Palliative Medicine | UNITED-STATES | WOMEN | PERSPECTIVE | ONCOLOGY | HIGH-RISK | LINE | CLASSIFICATION | PREVALENCE | INTRAEPITHELIAL NEOPLASIA | LESIONS | Adenocarcinoma - pathology | Genetic Testing | Age Factors | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | DNA, Viral - isolation & purification | Uterine Cervical Neoplasms - pathology | Mass Screening - methods | Papillomaviridae - genetics | Papillomavirus Infections - pathology | Paraffin Embedding | Young Adult | Papillomaviridae - immunology | Carcinoma, Adenosquamous - prevention & control | Polymerase Chain Reaction | Aged, 80 and over | Adult | Female | Papillomavirus Infections - virology | Retrospective Studies | Carcinoma, Adenosquamous - epidemiology | Carcinoma, Adenosquamous - pathology | Papillomavirus Vaccines - therapeutic use | Cross-Sectional Studies | Carcinoma, Squamous Cell - epidemiology | Neoplasm Invasiveness | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Genotype | Linear Models | Logistic Models | International Cooperation | Carcinoma, Squamous Cell - prevention & control | Adenocarcinoma - virology | Adenocarcinoma - prevention & control | Papillomavirus Infections - prevention & control | Adolescent | Uterine Cervical Neoplasms - virology | Aged | Adenocarcinoma - epidemiology | Carcinoma, Adenosquamous - virology | Papillomaviruses | Prevention | Medical colleges | Speech therapists | Oncology, Experimental | Genetic aspects | Agriculture | Research | College teachers | Papillomavirus infections | Cervical cancer | Cancer
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9580, pp. 2161 - 2170
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 89 - 99
Summary Background Cervical intraepithelial neoplasia grade 2 or greater (CIN2+) is the surrogate endpoint used in licensure trials of human papillomavirus... 
Hematology, Oncology and Palliative Medicine | COUNTRIES | ONCOLOGY | PARTICLE VACCINE | ADENOCARCINOMA | HPV VACCINATION | ADOLESCENT WOMEN | FOLLOW-UP | YOUNG-WOMEN | CANCER | CARCINOMA | HUMAN-PAPILLOMAVIRUS INFECTION | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adenocarcinoma - pathology | Adjuvants, Immunologic - administration & dosage | Age Factors | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Time Factors | Adult | Female | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Adenocarcinoma - virology | Cervical Intraepithelial Neoplasia - virology | Adenocarcinoma - diagnosis | Adenocarcinoma - prevention & control | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Australia | Human papillomavirus 16 - genetics | Medical colleges | Care and treatment | Cervix dysplasia | Vaccination | Oncology, Experimental | Clinical trials | Vaccines | Research | Prevention | Sexually transmitted diseases | Analysis | Cross infection | Adults | Nosocomial infections | Children | Papillomavirus infections | Health aspects | Cervical cancer | Public health | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 100 - 110
Summary Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types in the... 
Hematology, Oncology and Palliative Medicine | UNITED-STATES | AGED 16-26 YEARS | ONCOLOGY | PARTICLE VACCINE | NEOPLASIA | MAJOR CAPSID PROTEIN | YOUNG-WOMEN | CANCER | HUMAN-PAPILLOMAVIRUS INFECTION | LESIONS | EPITOPES | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Precancerous Conditions - diagnosis | Precancerous Conditions - virology | Time Factors | Adult | Female | Papillomavirus Infections - virology | Precancerous Conditions - pathology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Cervical Intraepithelial Neoplasia - virology | Cross Reactions | Antigens, Viral - immunology | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Precancerous Conditions - prevention & control | Australia | Human papillomavirus 16 - genetics | Prevention | Medical colleges | Analysis | Oncology, Experimental | Clinical trials | Cross infection | Vaccines | Nosocomial infections | Research | Papillomavirus infections | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 2016, Volume 11, Issue 1, pp. e0147029 - e0147029
BACKGROUND: In addition to HPV, high parity and hormonal contraceptives have been associated with cervical cancer (CC). However, most of the evidence comes... 
WOMEN | PARITY | CARCINOGENESIS | MULTIDISCIPLINARY SCIENCES | REPRODUCTIVE FACTORS | REPLACEMENT THERAPY | SMOKING | INTRAEPITHELIAL NEOPLASIA | HUMAN-PAPILLOMAVIRUS INFECTION | ORAL-CONTRACEPTIVES | HPV | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Chlamydia trachomatis - immunology | Risk | Hormone Replacement Therapy - adverse effects | Antibodies, Viral - blood | Papillomavirus Infections - blood | Case-Control Studies | Young Adult | Gonadal Steroid Hormones - physiology | Papillomaviridae - immunology | Intrauterine Devices | Adult | Female | Herpes Genitalis - blood | Cervical Intraepithelial Neoplasia - epidemiology | Contraceptives, Oral, Hormonal - adverse effects | Carcinoma, Squamous Cell - epidemiology | Gonadal Steroid Hormones - adverse effects | Papillomavirus Infections - epidemiology | Chlamydia Infections - epidemiology | Uterine Cervical Neoplasms - physiopathology | Carcinoma, Squamous Cell - physiopathology | Cervical Intraepithelial Neoplasia - physiopathology | Chlamydia Infections - blood | Pregnancy | Herpesvirus 2, Human - immunology | Reproductive History | Aged | Herpes Genitalis - epidemiology | Nutrition | Invasiveness | Health risks | Antibodies | Risk reduction | Chlamydia trachomatis | Cervix | Risk analysis | Epidemiology | Carcinogenesis | Risk factors | Confidence intervals | Contraceptives | Sexually transmitted diseases | Carcinogens | Human papillomavirus | Contraceptives (oral) | Quality | Hormone replacement therapy | Health risk assessment | Intrauterine devices | Cervical cancer | Cancer | Index Medicus | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article